443
We present the cases of two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS) who developed inflammatory musculoskeletal manifestations, following IFN-beta therapy.
 two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS): Subject; two: Subject.Population; female: Subject.Gender; inflammatory musculoskeletal manifestations: Effect; IFN-beta: Treatment; IFN-beta: Treatment.Drug; relapsing-remitting multiple sclerosis: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS): Subject; two: Subject.Population; female: Subject.Gender; inflammatory musculoskeletal manifestations: Effect; IFN-beta: Treatment; IFN-beta: Treatment.Drug; relapsing-remitting multiple sclerosis: Treatment.Disorder